Skip to Content

尊敬的客户：

目前国际形势复杂多变，关税政策尚不明朗，这可能对我们的产品价格产生一定影响。在此情况下，我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性，如果您选择在此期间下单，我们将保留根据实际情况调整价格的权利。同时，我们也理解市场变化可能给您带来的困扰，因此如果在订单实际发货前因关税政策变动导致价格出现较大波动，默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
All Photos(1)

Key Documents

Safety Information

N6530

Sigma-Aldrich

N1 Medium Supplement (100×)

solution, sterile-filtered, suitable for cell culture

Synonym(s):

N1 Supplement

Sign Into View Organizational & Contract Pricing

Select a Size

25 MG
¥1,319.86
200 MG
¥3,601.49
500 MG
¥6,917.80
1 G
¥11,568.31

¥1,319.86

Available to ship on2025年4月24日Details

Request a Bulk Order
All Photos(1)

Select a Size

Change View
25 MG
¥1,319.86
200 MG
¥3,601.49
500 MG
¥6,917.80
1 G
¥11,568.31

About This Item

UNSPSC Code:
12352207
NACRES:
NA.77

¥1,319.86

Available to ship on2025年4月24日Details

Request a Bulk Order

sterility

sterile-filtered

Quality Level

300

form

solution

technique(s)

cell culture | mammalian: suitable

impurities

endotoxin, tested

storage temp.

2-8°C

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
700002P700054P700061P
DC-胆固醇HCl Avanti Research™ - A Croda Brand 700001P, powder

700001P

DC-胆固醇HCl

F7-Cholesterol Avanti Research™ - A Croda Brand

700002P

F7-Cholesterol

5α,6β-dihydroxycholestanol Avanti Research™ - A Croda Brand

700054P

5α,6β-dihydroxycholestanol

24(S)-羟基胆固醇 Avanti Research™ - A Croda Brand

700061P

24(S)-羟基胆固醇

packaging

pkg of 1 × 1 g (700001P-1g), pkg of 1 × 25 mg (700001P-25mg), pkg of 1 × 200 mg (700001P-200mg), pkg of 1 × 500 mg (700001P-500mg)

packaging

pkg of 1 × 5 mg (700002P-5mg)

packaging

pkg of 1 × 25 mg (700054P-25mg), pkg of 1 × 5 mg (700054P-5mg)

packaging

pkg of 1 × 1 mg (700061P-1mg), pkg of 1 × 5 mg (700061P-5mg)

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

form

powder

form

powder

form

powder

form

powder

manufacturer/tradename

Avanti Polar Lipids 700001P

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids

General description

N1 Medium Supplement (100×) can be used as a supplement to produce complete N1 neural cell growth media or closely related media.

Application

N1 Medium Supplement (100×) has been used as:
  • a component of the proliferation medium for culturing oligodendrocyte-like cells and neuroblastoma cells[1]
  • a supplement in the Dulbecco′s modified Eagle medium (DMEM/F12) to culture human oligodendrocytes[2]
  • a component of the α-minimum essential medium (MEM) for culturing induced primary retinal pigment epithelium (ipRPE) monolayers[3]

Other Notes

Contains 0.5mg/ml recombinant human insulin, 0.5mg/ml human transferrin (partially iron-saturated), 0.5μg/ml sodium selenite, 1.6mg/ml putrescine, and 0.73μg/ml progesterone.

Preparation Note

Prepared in Earle′s Balanced Salt Solution (EBSS) without phenol red.

related product

Product No.
Description
Pricing

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

常规特殊物品

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    0000336172
    0000277714
    0000277714
    0000336172
    SLCM2577

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Ludmila A Voloboueva et al.
    Investigative ophthalmology & visual science, 46(11), 4302-4310 (2005-10-27)
    To determine whether (R)-alpha-lipoic acid (LA) protects cultured human fetal retinal pigment epithelial (hfRPE) cells against oxidative injury and identify the pathways that may mediate protection. Cultured hfRPE cells were pretreated with various concentrations of LA for 14 to 16
    Miguel Flores-Bellver et al.
    Journal of extracellular vesicles, 10(13), e12165-e12165 (2021-11-10)
    Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. Drusen are key contributors to the etiology of AMD and the ability to modulate drusen biogenesis could lead to therapeutic strategies to slow or halt AMD progression. The mechanisms
    Lucia Lichvarova et al.
    Scientific reports, 10(1), 12518-12518 (2020-07-23)
    An amendment to this paper has been published and can be accessed via a link at the top of the paper.
    Michael Craigie et al.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 13(2), 126-142 (2017-11-22)
    JC virus (JCV) is a human polyomavirus and the etiologic agent of the demyelinating disease progressive multifocal leukoencephalopathy (PML). PML is observed in patients with underlying immunocompromising conditions, suggesting that neuro-immune interactions between peripheral immune cells and neuro-glia play an
    Nicholas W Kieran et al.
    Journal of neuroinflammation, 19(1), 10-10 (2022-01-08)
    Astrocytes are the most numerous glial cell type with important roles in maintaining homeostasis and responding to diseases in the brain. Astrocyte function is subject to modulation by microRNAs (miRs), which are short nucleotide strands that regulate protein expression in
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service